Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.

导出 LinkOut

翻译打印收藏纠错

第一作者： Chloé,Rancoule

第一单位： Radiotherapy Department, Lucien Neuwirth Cancer Institute, St Priest en Jarez, France.

作者： Chloé,Rancoule ^[1] ; Alexis,Vallard ^[1] ; Sophie,Espenel ^[1] ; Jean-Baptiste,Guy ^[2] ; Yaoxiong,Xia ^[1] ; Anis,El Meddeb Hamrouni ^[1] ; Claire,Rodriguez-Lafrasse ^[3] ; Cyrus,Chargari ^[4] ; Eric,Deutsch ^[5] ; Nicolas,Magné ^[6]

作者单位： Radiotherapy Department, Lucien Neuwirth Cancer Institute, St Priest en Jarez, France. ^[1] Radiotherapy Department, Lucien Neuwirth Cancer Institute, St Priest en Jarez, France; Radiobiology Laboratory, Lyon Medicine University, Lyon, France. ^[2] Radiobiology Laboratory, Lyon Medicine University, Lyon, France; Hospices-Civils-de-Lyon, Lyon Hospital, Lyon, France. ^[3] Radiotherapy Department, Gustave Roussy Campus Cancer, Grand Paris, France; INSERM 1030, Molecular Radiotherapy, Gustave Roussy Campus Cancer, Grand Paris, France; Institute of "Recherche Biomédicale des Armées", Paris, France. ^[4] Radiotherapy Department, Gustave Roussy Campus Cancer, Grand Paris, France. ^[5] Radiotherapy Department, Lucien Neuwirth Cancer Institute, St Priest en Jarez, France; Radiobiology Laboratory, Lyon Medicine University, Lyon, France. Electronic address: nicolas.magne@icloire.fr. ^[6]

关键词 Clinical trials Immune system Immunotherapy Monoclonal antibodies SCCHN Treatment combination

主题词癌, 鳞状细胞(Carcinoma, Squamous Cell);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);免疫疗法(Immunotherapy)

DOI 10.1016/j.oraloncology.2016.09.002

PMID 27623508

发布时间 2021-01-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交